Physician profile
Steven Davidoff
NPI 1841250685
$1,786.89
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,743 · 2020: $14.57 · 2021: $13.34 · 2024: $15.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $678.19 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $364.75 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $205.80 | 2019 | |
| Allergan, INC. | $162.08 | 2019 | |
| Qol Medical, LLC | $129.15 | 2019 | |
| Janssen Biotech, INC. | $108.43 | 2019 | |
| Boston Scientific Corporation | $29.84 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Ucb, INC. | $29.25 | 2019 | |
| Gilead Sciences, INC. | $23.82 | 2019 | |
| Janssen Scientific Affairs, LLC | $15.00 | 2019 | |
| Ironwood Pharmaceuticals, INC | $14.62 | 2019 | |
| Pfizer INC. | $14.19 | 2019 | |
| Ferring Pharmaceuticals INC. | $11.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Davidoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.